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Here, we describe the draft genome sequence of Actinoplanes utahensisNRRL 12052, a filamentous bacterium that encodes an
aculeacin A acylase and a putativeN-acyl-homoserine lactone acylase of biotechnological interest. Moreover, several nonribo-
somal peptide synthase (NRPS) and polyketide synthase (PKS) clusters and antibiotic resistance genes have been identified.
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Actinoplanes utahensisNRRL12052 is aGram-positive filamen-tous bacterium able to hydrolyze aliphatic acyl-side chains of
many antimicrobials, such as penicillins (1), lipopeptides (2–6),
glycopeptides (7, 8), and capsaicin (9). Its draft genome was ob-
tained at the Fundación Parque Científico de Madrid (Spain)
from a shotgun library constructed and sequenced using Tita-
nium 454 GS-FLX instrument (Roche Diagnostics, Banford, CT)
according to the manufacturer, except that the emulsion em-
ployed in the live amplification mix contained an emulsion PCR
(emPCR) additive instead of water. The genome comprises
9.5 Mb with 71.2% GC content, obtaining 396 large contigs
from 2.1 106 reads byNewbler 2.5.3, which were reduced to 141
contigs by manual assembly (39.4-fold coverage). Seventy-seven
RNA genes (6 rRNA and 71 tRNA) and 8,744 coding sequences
(CDSs) were detected by RAST (10), 730 assigned with putative
functions and 3,010 hypothetical proteins, including a putative
N-acyl-homoserine lactone acylase (AHLA) and the aculeacin A
acylase (AAC) (1, 6), which play critical roles in the generation of
building blocks to synthesize therapeutic antimicrobials. How-
ever, the physiological roles remain unknown. According to anti-
SMASH (11), this genome contains 24 clusters, some of them
associated with nonribosomal peptide synthases (NRPSs),
polyketide synthases (PKSs), and bacteriocin, among others. The
AAC-encoding (aac) gene is located within the third cluster, in-
volved in the biosynthesis of an NRPS with the monomer predic-
tion (gly-nrp-nrp-nrp)  (nrp-nrp). The putative AHLA-
encoding (ahl) gene is located at 88 kb upstream within the fifth
cluster which codifies for another NRPS with the monomer pre-
diction (nrp) (tyr–pro).
The ahl gene encodes a protein of 808 amino acids (aa), which
shows modular organization including a predicted 33-aa signal
peptide (12), an -subunit of 20.9 kDa, and a -subunit of
60.4 kDa, This enzyme presents the essential catalytic amino acid
that is conserved in other acylases (13), suggesting that it is in-
volved in a quorum-quenching mechanism.
A single aac gene was detected in this microorganism, suggest-
ing that the membrane-associated echinocandin B deacylase (5,
14, 15), which only differs from the soluble AAC form (6, 16) by
two additional N-terminal amino acids, is encoded by the same
gene.
Furthermore, RAST detected 26 subsystems involved in the
metabolism of carbohydrates, amino acids, and proteins, among
others. Likewise, genes involved in the mechanisms of virulence,
disease, and defense were detected, highlighting the presence of
tetracycline, fluoroquinolones, and vancomycin resistance genes
as well as 16 -lactamases.
A phylogenetic tree by MEGA6 (17) was inferred from 16S
rRNA (1520 bp), showing that A. purpeobrunneus IFO 14020 and
A. derwentensis IFO 14935 are closely located. However, a very
evolutionary difference to other bacteria was displayed when a
deep comparative analysis with its whole genome was performed
by JSpecies (18).
Nucleotide sequence accessionnumbers.Thiswhole-genome
shotgun project has been deposited at GenBank under accession
no. JRTT00000000. The version described in this paper is the first
version, JRTT01000000.
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